Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_assertion description "[S100P has been shown to mediate tumor growth, metastasis and invasion through the binding of Ca(2+) ions, receptor for advanced glycation end products, cytoskeletal protein ezrin, calcyclin-binding protein/Siah-1-interacting protein and cathepsin D. S100P could potentially serve as diagnostic marker, prognostic/predictive indicator and therapy target for different carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_assertion evidence source_evidence_literature NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_assertion SIO_000772 21947242 NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_assertion wasDerivedFrom befree-20140225 NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_assertion wasGeneratedBy ECO_0000203 NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP820152.RAiy-HQZLxwXQr8fG9eImZCBc30RL7rC186cMEwTe_F4A130_provenance.